|
|
||||||||
1d subunit present in cardiac muscle
Departments of 1Medicine and 2Physiology, University of Wisconsin, Madison, Wisconsin; and 3Department of Pharmacology, University of Iowa, Iowa City, Iowa
Submitted 12 April 2004 ; accepted in final form 21 December 2004
Recent studies have identified a growing diversity of splice variants of auxiliary Ca2+ channel Cav
subunits. The Cav
1d isoform encodes a putative protein composed of the amino-terminal half of the full-length Cav
1 isoform and thus lacks the known high-affinity binding site that recognizes the Ca2+ channel
1-subunit, the
-binding pocket. The present study investigated whether the Cav
1d subunit is expressed at the protein level in heart, and whether it exhibits any of the functional properties typical of full-length Cav
subunits. On Western blots, an antibody directed against the unique carboxyl terminus of Cav
1d identified a protein of the predicted molecular mass of 23 kDa from canine and human hearts. Immunocytochemistry and surface-membrane biotinylation experiments in transfected HEK-293 cells revealed that the full-length Cav
1b subunit promoted membrane trafficking of the pore-forming
1C (Cav1.2)-subunit to the surface membrane, whereas the Cav
1d subunit did not. Whole cell patch-clamp analysis of transfected HEK-293 cells demonstrated no effect of coexpression of the Cav
1d with the
1C-subunit compared with the 15-fold larger currents and leftward shift in voltage-dependent activation induced by full-length Cav
1b coexpression. In contrast, cell-attached patch single-channel studies demonstrated that coexpression of either Cav
1b or Cav
1d significantly increased mean open probability four- to fivefold relative to the
1C-channels alone, but only Cav
1b coexpression increased the number of channels observed per patch. In conclusion, the Cav
1d isoform is expressed in heart and can modulate the gating of L-type Ca2+ channels, but it does not promote membrane trafficking of the channel complex.
electrophysiology; ion; heart; splice variant
This article has been cited by other articles:
![]() |
S. Telemaque, S. Sonkusare, T. Grain, S. W. Rhee, J. R. Stimers, N. J. Rusch, and J. D. Marsh Design of Mutant {beta}2 Subunits as Decoy Molecules to Reduce the Expression of Functional Ca2+ Channels in Cardiac Cells J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 37 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sonkusare, M. Fraer, J. D. Marsh, and N. J. Rusch Disrupting Calcium Channel Expression To Lower Blood Pressure: New Targeting of a Well-Known Channel Mol. Interv., December 1, 2006; 6(6): 304 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Leroy, M. S. Richards, A. J. Butcher, M. Nieto-Rostro, W. S. Pratt, A. Davies, and A. C. Dolphin Interaction via a Key Tryptophan in the I-II Linker of N-Type Calcium Channels Is Required for {beta}1 But Not for Palmitoylated {beta}2, Implicating an Additional Binding Site in the Regulation of Channel Voltage-Dependent Properties J. Neurosci., July 27, 2005; 25(30): 6984 - 6996. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |